Cargando…
p-Cresol Sulfate Is a Sensitive Urinary Marker of Fecal Microbiota Transplantation and Antibiotics Treatments in Human Patients and Mouse Models
Fecal microbiota transplantation (FMT) has emerged as a highly effective therapy for recurrent Clostridioides difficile infection (rCDI) and also a potential therapy for other diseases associated with dysbiotic gut microbiota. Monitoring metabolic changes in biofluids and excreta is a noninvasive ap...
Autores principales: | Zhou, Yuyin, Bi, Zheting, Hamilton, Matthew J., Zhang, Li, Su, Rui, Sadowsky, Michael J., Roy, Sabita, Khoruts, Alexander, Chen, Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572327/ https://www.ncbi.nlm.nih.gov/pubmed/37834066 http://dx.doi.org/10.3390/ijms241914621 |
Ejemplares similares
-
Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation
por: Shankar, Vijay, et al.
Publicado: (2014) -
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016) -
The fecal microbiome and serum concentrations of indoxyl sulfate and p‐cresol sulfate in cats with chronic kidney disease
por: Summers, Stacie C., et al.
Publicado: (2018) -
Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
por: Staley, Christopher, et al.
Publicado: (2018) -
Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection
por: Staley, Christopher, et al.
Publicado: (2019)